eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Research ArticleImmunology
Activation of the Transcription Factor c-Maf in T Cells Is Dependent on the CARMA1-IKKβ Signaling Cascade
- Marzenna Blonska1,2,
- Donghyun Joo1,3,
- Roza I. Nurieva2,4,
- Xueqiang Zhao1,2,
- Paul Chiao1,2,3,
- Shao-Cong Sun2,3,4,
- Chen Dong2,4, and
- Xin Lin1,2,3,4,*
- 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- 2Center for Inflammation and Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- 3Cancer Biology Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
- 4Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- ↵*Corresponding author. E-mail: xllin{at}mdanderson.org
See allHide authors and affiliations
Science Signaling 17 Dec 2013:
Vol. 6, Issue 306, pp. ra110
DOI: 10.1126/scisignal.2004273
Vol. 6, Issue 306, pp. ra110
DOI: 10.1126/scisignal.2004273
Marzenna Blonska
1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
2Center for Inflammation and Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Donghyun Joo
1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
3Cancer Biology Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Roza I. Nurieva
2Center for Inflammation and Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
4Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Xueqiang Zhao
1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
2Center for Inflammation and Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Paul Chiao
1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
2Center for Inflammation and Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
3Cancer Biology Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
Shao-Cong Sun
2Center for Inflammation and Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
3Cancer Biology Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
4Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Chen Dong
2Center for Inflammation and Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
4Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Xin Lin
1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
2Center for Inflammation and Cancer, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
3Cancer Biology Program, The University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA.
4Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Submit a Response to This Article
No eLetters have been published for this article.